CL2014003116A1 - Compuestos derivados de metanotiona,con actividad antiviral; metodo de preparacion; composicion farmaceutica; y un metodo de tratamiento de una infeccion viral, tal que la infeccion viral es influenza - Google Patents

Compuestos derivados de metanotiona,con actividad antiviral; metodo de preparacion; composicion farmaceutica; y un metodo de tratamiento de una infeccion viral, tal que la infeccion viral es influenza

Info

Publication number
CL2014003116A1
CL2014003116A1 CL2014003116A CL2014003116A CL2014003116A1 CL 2014003116 A1 CL2014003116 A1 CL 2014003116A1 CL 2014003116 A CL2014003116 A CL 2014003116A CL 2014003116 A CL2014003116 A CL 2014003116A CL 2014003116 A1 CL2014003116 A1 CL 2014003116A1
Authority
CL
Chile
Prior art keywords
viral infection
methanethione
influenza
treating
preparation
Prior art date
Application number
CL2014003116A
Other languages
English (en)
Inventor
Mohammed Homman
Ngarita Kingi
Jan Bergman
Robert Berg
Original Assignee
Vironova Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48444409&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2014003116(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vironova Ab filed Critical Vironova Ab
Publication of CL2014003116A1 publication Critical patent/CL2014003116A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CL2014003116A 2012-05-18 2014-11-17 Compuestos derivados de metanotiona,con actividad antiviral; metodo de preparacion; composicion farmaceutica; y un metodo de tratamiento de una infeccion viral, tal que la infeccion viral es influenza CL2014003116A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261648700P 2012-05-18 2012-05-18
US201261659516P 2012-06-14 2012-06-14
US201261666286P 2012-06-29 2012-06-29
US201361774991P 2013-03-08 2013-03-08

Publications (1)

Publication Number Publication Date
CL2014003116A1 true CL2014003116A1 (es) 2015-08-07

Family

ID=48444409

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014003116A CL2014003116A1 (es) 2012-05-18 2014-11-17 Compuestos derivados de metanotiona,con actividad antiviral; metodo de preparacion; composicion farmaceutica; y un metodo de tratamiento de una infeccion viral, tal que la infeccion viral es influenza

Country Status (21)

Country Link
US (1) US9359310B2 (es)
EP (1) EP2870141B1 (es)
JP (2) JP6484168B2 (es)
KR (1) KR102092207B1 (es)
CN (1) CN104540810B (es)
AU (1) AU2013261735B2 (es)
BR (1) BR112014028632B1 (es)
CA (1) CA2879816C (es)
CL (1) CL2014003116A1 (es)
DK (1) DK2870141T3 (es)
EA (1) EA029044B1 (es)
ES (1) ES2657942T3 (es)
HK (1) HK1210165A1 (es)
IL (1) IL235742A0 (es)
IN (1) IN2014DN10658A (es)
MX (1) MX356846B (es)
MY (1) MY169094A (es)
NZ (1) NZ702073A (es)
SG (1) SG11201407703QA (es)
WO (1) WO2013171334A1 (es)
ZA (1) ZA201409220B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ702073A (en) * 2012-05-18 2017-07-28 Vironova Influenza Ab Methanethione compounds having antiviral activity
CN107056762B (zh) * 2016-12-22 2020-08-28 四川百利药业有限责任公司 一种用作抗流感病毒的双羰基类似物
WO2021204923A1 (en) 2020-04-09 2021-10-14 Vironova Medical Ab Antiviral agents
WO2021204924A1 (en) 2020-04-09 2021-10-14 Vironova Medical Ab Compounds for use in the treatment of hypercytokinemia

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642390B2 (en) 2001-07-11 2003-11-04 Lexicon Pharmaceuticals, Inc. One step synthesis of 1,2,3-triazole carboxylic acids
EP1590329A1 (fr) * 2003-01-28 2005-11-02 Aventis Pharma S.A. Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
EP2278879B1 (en) 2008-04-21 2016-06-15 PATH Drug Solutions Compounds, compositions and methods comprising oxadiazole derivatives
IN2012DN01254A (es) * 2009-08-05 2015-05-15 Versitech Ltd
MX2013003227A (es) * 2010-09-28 2013-05-31 Bristol Myers Squibb Co Nuevos analogos de piperazina con grupos heteroarilo sustituidos como antivirales de la influenza de espectro amplio.
EP2484655A1 (en) 2011-02-04 2012-08-08 Vironova AB A thionation process and a thionating agent
NZ702073A (en) * 2012-05-18 2017-07-28 Vironova Influenza Ab Methanethione compounds having antiviral activity
JP6762767B2 (ja) * 2016-06-01 2020-09-30 キヤノン株式会社 撮像素子、撮像装置、および撮像信号処理方法

Also Published As

Publication number Publication date
US9359310B2 (en) 2016-06-07
JP2015517516A (ja) 2015-06-22
AU2013261735B2 (en) 2017-07-20
JP2018065817A (ja) 2018-04-26
IN2014DN10658A (es) 2015-08-28
NZ702073A (en) 2017-07-28
CA2879816C (en) 2020-07-07
CN104540810A (zh) 2015-04-22
CN104540810B (zh) 2017-01-18
IL235742A0 (en) 2015-02-01
ZA201409220B (en) 2016-08-31
MY169094A (en) 2019-02-18
MX2014014007A (es) 2015-05-11
KR102092207B1 (ko) 2020-03-23
BR112014028632A8 (pt) 2018-04-03
HK1210165A1 (en) 2016-04-15
EA201401277A1 (ru) 2015-04-30
EP2870141A1 (en) 2015-05-13
JP6484168B2 (ja) 2019-03-13
SG11201407703QA (en) 2015-01-29
EA029044B1 (ru) 2018-02-28
AU2013261735A1 (en) 2015-01-22
CA2879816A1 (en) 2013-11-21
MX356846B (es) 2018-06-18
WO2013171334A1 (en) 2013-11-21
ES2657942T3 (es) 2018-03-07
DK2870141T3 (da) 2018-01-29
KR20150012289A (ko) 2015-02-03
BR112014028632A2 (pt) 2017-06-27
BR112014028632B1 (pt) 2020-01-28
US20150133468A1 (en) 2015-05-14
EP2870141B1 (en) 2017-11-22

Similar Documents

Publication Publication Date Title
HK1220935A1 (zh) 治療乙型肝炎病毒感染的方法和藥物組合物
HK1203944A1 (zh) 用於治療和預防乙型肝炎病毒感染的 -甲基-二氫嘧啶類
CL2013001428A1 (es) Compuesto que inhibe la actividad del virus de la hepatitis c (hcv); composición farmacéutica que comprende el compuesto; método de tratamiento de hepatitis c.
CL2015003615A1 (es) Nucleósidos sustituidos, nucleótidos y análogos de los mismos.
HK1210152A1 (en) 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection 6-
CL2014000919A1 (es) Compuestos derivados de acido 2-tert-butoxi-2-(5-metilbenzo[d]tiazol-6-il) acetico; composicion farmaceutica que los comprende; metodo para tratar una infeccion por vih; y su uso para tratar una infeccion por vih.
CL2012001959A1 (es) Compuestos derivados del acido tiofeno-2-carboxilico, inhibidores de virus flaviviridae; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion viral por flaviviridae.
CL2014001641A1 (es) Compuestos derivados de nucleosidos sustituidos, nucleotidos y analogos de los mismos; composicion farmaceutica; y uso para mejorar o tratar una infeccion viral.
BR112014010545A2 (pt) composição farmacêutica, método para tratar um paciente infectado com vírus da hepatite c, uso de uma composição
CL2014000393A1 (es) Compuestos derivados de benzofurano y sus sales, como inhibidores del virus de hepatitis c; composicion farmaceutica que los comprende; y su uso para el tratamiento o la prevencion de una infeccion por el virus de hepatitis c o de una enfermedad asociada con dicha infeccion.
UY34420A (es) ?métodos de tratamiento del virus de la hepatitis c con que de gs-7977 y ribavirina, composiciones y usos"
EP2769973A4 (en) INGENANE TYPE DITERPENE COMPOUND AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF VIRAL INFECTIOUS DISEASES CONTAINING THE SAME
CL2014003012A1 (es) Formulación en capsulas que comprende al menos un compuesto de formula (i), solubilizado; metodo de administracion de la formulacion; uso para tratar una infeccion por el virus de la hepatitis c.
CL2014000394A1 (es) Uso de compuestos fenil-benzofuran-sulfamido sustituidos para el tratamiento del virus de la hepatitis c (hcv); y composicion farmaceutica que comprende a estos compuestos fenil-benzofuran-sulfamido sustituidos.
CL2014003116A1 (es) Compuestos derivados de metanotiona,con actividad antiviral; metodo de preparacion; composicion farmaceutica; y un metodo de tratamiento de una infeccion viral, tal que la infeccion viral es influenza
BR112013024904A2 (pt) composto e método ex vivo de redução da infecciosidade ou de inativação de um vírus da hepatite c
CL2015003752A1 (es) Inhibidores de replicación viral, su proceso de preparación y sus uso terapeutico
KR101501876B9 (ko) 자일리톨을 유효성분으로 함유하는 인플루엔자 바이러스 감염증 예방 또는 치료용 조성물
CO6801768A2 (es) Procesos para la preparación de inhibidores del virus de la hepatitis
DK2939665T3 (da) Farmaceutisk sammensætning til behandling af hiv-infektioner
IN2011CH03893A (es)
WO2014121170A3 (en) Antiviral compounds
HK1205680A1 (en) Agent for the treatment of hepatitis c virus
CL2013002235A1 (es) Composicion farmaceutica que comprende una combinacion de un compuesto derivado de tiacumicina y un antiinflamatorio; y uso para tratar una infeccion causada por una bacteria.
ZA201407866B (en) Composition for the prevention and treatment of viral infections caused by retroviruses